106 related articles for article (PubMed ID: 7982239)
61. The 180 splice variant of NCAM-containing exon 18-is specifically expressed in small cell lung cancer cells.
Vander Borght A; Duysinx M; Broers JLV; Ummelen M; Falkenberg FW; Hahnel C; van der Zeijst BAM
Transl Lung Cancer Res; 2018 Jun; 7(3):376-388. PubMed ID: 30050775
[TBL] [Abstract][Full Text] [Related]
62. Modification of beta-2-microglobulin in sera from patients with small cell lung cancer: evidence for involvement of a serine protease.
Nissen MH; Bjerrum OJ; Plesner T; Wilken M; Rørth M
Clin Exp Immunol; 1987 Feb; 67(2):425-32. PubMed ID: 3038438
[TBL] [Abstract][Full Text] [Related]
63. Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancer.
Ornadel D; Ledermann JA; Eagle K; Pedley RB; Boxer G; Ward SE; Olabiran Y; Bomanji J
Br J Cancer; 1998; 77(1):103-9. PubMed ID: 9459153
[TBL] [Abstract][Full Text] [Related]
64. NCAM: a surface marker for human small cell lung cancer cells.
Aletsee-Ufrecht MC; Langley K; Rotsch M; Havemann K; Gratzl M
FEBS Lett; 1990 Jul; 267(2):295-300. PubMed ID: 2165922
[TBL] [Abstract][Full Text] [Related]
65. [A clinical study of ProGRP as a new tumor marker for small cell lung cancer].
Yu B; Liu Q; Chen L
Zhongguo Fei Ai Za Zhi; 2003 Jun; 6(3):209-10. PubMed ID: 21266123
[TBL] [Abstract][Full Text] [Related]
66. NCAM and lung cancer.
Michalides R; Kwa B; Springall D; van Zandwijk N; Koopman J; Hilkens J; Mooi W
Int J Cancer Suppl; 1994; 8():34-7. PubMed ID: 8194895
[TBL] [Abstract][Full Text] [Related]
67. Measurement of serum p53 protein in patients with small cell lung cancer and results of its clinicopathological evaluation.
Segawa Y; Takigawa N; Mandai K; Maeda Y; Takata I; Fujimoto N; Jinno K
Lung Cancer; 1997 Mar; 16(2-3):229-38. PubMed ID: 9152954
[TBL] [Abstract][Full Text] [Related]
68. Elevated serum levels of fetal antigen 1,a member of the epidermal growth factor superfamily, in patients with small cell lung cancer.
Harken Jensen C; Drivsholm L; Laursen I; Teisner B
Tumour Biol; 1999; 20(5):256-62. PubMed ID: 10436418
[TBL] [Abstract][Full Text] [Related]
69. Hot spots of antigenicity in the neural cell adhesion molecule NCAM.
Gerardy-Schahn R; Eckhardt M
Int J Cancer Suppl; 1994; 8():38-42. PubMed ID: 7515028
[TBL] [Abstract][Full Text] [Related]
70. Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients.
Stovold R; Meredith SL; Bryant JL; Babur M; Williams KJ; Dean EJ; Dive C; Blackhall FH; White A
Br J Cancer; 2013 Apr; 108(8):1704-11. PubMed ID: 23519056
[TBL] [Abstract][Full Text] [Related]
71. Serological tumor markers for small cell lung cancer and their therapeutic implications.
Vangsted AJ
APMIS; 1994 Aug; 102(8):561-80. PubMed ID: 7946258
[TBL] [Abstract][Full Text] [Related]
72. Detection at diagnosis of tumor cells in bone marrow aspirates of patients with small-cell lung cancer (SCLC) and clinical correlations.
Pasini F; Pelosi G; Mostacci R; Santo A; Masotti A; Spagnolli P; Recaldin E; Cetto GL
Ann Oncol; 1995 Jan; 6(1):86-8. PubMed ID: 7536032
[TBL] [Abstract][Full Text] [Related]
73. Interferon-inhibiting activities in sera of patients with lung cancer.
Karmaniolas K; Tsantakis G; Havredaki M
Arch Immunol Ther Exp (Warsz); 1997; 45(1):61-5. PubMed ID: 9090442
[TBL] [Abstract][Full Text] [Related]
74. On the emerging role of chemistry in the fashioning of biologics: synthesis of a bidomainal fucosyl GM1-based vaccine for the treatment of small cell lung cancer.
Nagorny P; Kim WH; Wan Q; Lee D; Danishefsky SJ
J Org Chem; 2009 Aug; 74(15):5157-62. PubMed ID: 19555091
[TBL] [Abstract][Full Text] [Related]
75. Expression of a neural cell adhesion molecule serum fragment is depressed in autism.
Plioplys AV; Hemmens SE; Regan CM
J Neuropsychiatry Clin Neurosci; 1990; 2(4):413-7. PubMed ID: 2136394
[TBL] [Abstract][Full Text] [Related]
76. No Impact of PolySia-NCAM Expression on Treatment Response in Neuroendocrine Neoplasms of the Lung.
Gagiannis D; Scheil A; Gagiannis S; Hackenbroch C; Horstkorte R; Steinestel K
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139538
[TBL] [Abstract][Full Text] [Related]
77. Prevalence of the Rhesus-negative phenotype in Caucasian patients with small-cell lung cancer (SCLC).
Cerny T; Fey MF; Oppliger R; Castiglione M; Nachbur B; Gertsch M; Gasser A; Joss RA; Thatcher N; Lind M
Int J Cancer; 1992 Sep; 52(3):504-6. PubMed ID: 1328070
[TBL] [Abstract][Full Text] [Related]
78. Topography of NCAM antigenic epitopes recognized by SCLC-cluster-1 antibodies. A consensus view.
Gerardy-Schahn R; Eckhardt M; Ledermann J; Kemshead JT
Int J Cancer Suppl; 1994; 8():27-9. PubMed ID: 7515027
[No Abstract] [Full Text] [Related]
79. The expression of S100B protein in serum of patients with brain metastases from small-cell lung cancer and its clinical significance.
Mu S; Ma H; Shi J; Zhen D
Oncol Lett; 2017 Dec; 14(6):7107-7110. PubMed ID: 29344141
[TBL] [Abstract][Full Text] [Related]
80. Serum NCAM: a potential new prognostic marker for multiple myeloma.
Kaiser U; Jaques G; Havemann K; Auerbach B
Blood; 1994 Feb; 83(3):871-3. PubMed ID: 8298146
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
